FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

James Eastham

Research Profile

Disorders

Procedures

Chemicals & Drugs

Concepts & Ideas

Anatomy

Prostate

Physiology

Disease Progression

Co-author Network

Publications

TOP 3
Jonathan L Silberstein; James A Eastham
Re: radical prostatectomy versus observation for localized prostate cancer.
Jonathan L Silberstein; James A Eastham
Lower urinary tract symptoms, benign prostatic hyperplasia, and prostate cancer: seek and ye shall find.
Kazuma Udo; Hikmat Al-Ahmadie; Lauren J Carlino; Angel M Cronin; James A Eastham; Anuradha Gopalan; Alexandra C Maschino; Victor E Reuter; Caroline J Savage; Peter T Scardino; SK Tickoo; Samson W Fine
Prognostic impact of subclassification of radical prostatectomy positive margins by linear extent and Gleason grade.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of James Eastham (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Jonathan L Silberstein; James A Eastham
Re: radical prostatectomy versus observation for localized prostate cancer.
European urology 2013;63(6):1130-1.
2013: Jonathan L Silberstein; James A Eastham
Lower urinary tract symptoms, benign prostatic hyperplasia, and prostate cancer: seek and ye shall find.
European urology 2013;63(6):1028-9.
2013: Kazuma Udo; Hikmat Al-Ahmadie; Lauren J Carlino; Angel M Cronin; James A Eastham; Anuradha Gopalan; Alexandra C Maschino; Victor E Reuter; Caroline J Savage; Peter T Scardino; SK Tickoo; Samson W Fine
Prognostic impact of subclassification of radical prostatectomy positive margins by linear extent and Gleason grade.
The Journal of urology 2013;189(4):1302-7.
2013: Joshua J Meeks; James A Eastham
Robotic salvage prostatectomy: underused but not for the inexperienced.
The Journal of urology 2013;189(2):413-4.
2013: Philip H Kim; Laura C Pinheiro; Jaspreet S Sandhu; Coral L Atoria; James A Eastham; Elena B Elkin
Trends in the use of incontinence procedures after radical prostatectomy: a population based analysis.
The Journal of urology 2013;189(2):602-8.
2013: Scott E Eggener; Larry Goldenberg; Robert Abouassaly; Raj Ayyathurai; Ryan K Berglund; James A Eastham; Steven J Jones; Eric A Klein; Alex Mueller; Peter T Scardino; Mark S Soloway; Cindy Soloway; Chris Zappavigna; Bertrand Guillonneau
A multi-institutional evaluation of active surveillance for low risk prostate cancer.
The Journal of urology 2013;189(1 Suppl):S19-25; discussion S25.
2012: Hebert Alberto Vargas; Junting Zheng; Chaya S Moskowitz; Peter Scardino; Amita Dave; Asim Afaq; Oguz Akin; James A Eastham; Debra Goldman; Hedvig Hricak
Magnetic resonance imaging for predicting prostate biopsy findings in patients considered for active surveillance of clinically low risk prostate cancer.
The Journal of urology 2012;188(5):1732-8.
2012: Hebert Alberto Vargas; Kristen L Zakian; Jingbo Zhang; Junting Zheng; Oguz Akin; James A Eastham; Debra A Goldman; Kent Kanao; Chaya S Moskowitz; Victor E Reuter; Peter T Scardino; Amita Dave; Hedvig Hricak
Performance characteristics of MR imaging in the evaluation of clinically low-risk prostate cancer: a prospective study.
Radiology 2012;265(2):478-87.
2012: James L Mohler; Elizabeth R Plimack; Julio M Pow-Sang; Mack Roach; Eric Rohren; Stan Rosenfeld; Sandy Srinivas; Seth A Strope; Jonathan Tward; Przemyslaw Twardowski; Patrick C Walsh; Andrew J Armstrong; Robert R Bahnson; Barry Boston; J Erik Busby; Anthony Victor D'Amico; James A Eastham; Charles A Enke; Thomas Farrington; Celestia S Higano; Maria Ho; Eric Mark Horwitz; Philip W Kantoff; Mark H Kawachi; Michael Kuettel; Richard J Lee; Gary R MacVicar; Arnold W Malcolm; David Miller; Dorothy A Shead
Prostate cancer, Version 3.2012: featured updates to the NCCN guidelines.
Journal of the National Comprehensive Cancer Network : JNCCN 2012;10(9):1081-7.
2012: Anuj Goenka; Marisa Kollmeier; Juan Martin Magsanoc; Xin Pei; Peter T Scardino; Michael Schechter; Brett Cox; James A Eastham; Michael J Zelefsky
Long-term outcomes after high-dose postprostatectomy salvage radiation treatment.
International journal of radiation oncology, biology, physics 2012;84(1):112-8.
2012: Kazuhito Matsushita; Badar M Mian; Peter T Scardino; Melanie Bernstein; Bernard H Bochner; Bilal I Chughtai; Elise De; James A Eastham; Lauren Ginsburg; Jaspreet S Sandhu
Pubovesical fistula: a rare complication after treatment of prostate cancer.
Urology 2012;80(2):446-51.
2012: Bob Djavan; James A Eastham; Leonard Gomella; Amir Kazzazi; Herbert Lepor; Judd Moul; Neal Shore; Samir Taneja; Bertrand Tombal; Per-Anders Abrahamsson; Philippa Cheetham; Seyed Saeid Dianat; E David Crawford
Testosterone in prostate cancer: the Bethesda consensus.
BJU international 2012;110(3):344-52.
2012: Sigrid Carlsson; James A Eastham; Hans Lilja; Monique Roobol; Peter Scardino; Andrew J Vickers; Jonas Hugosson
Prostate cancer screening: facts, statistics, and interpretation in response to the US Preventive Services Task Force Review.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012;30(21):2581-4.
2012: Behfar Ehdaie; Coral L Atoria; James A Eastham; Andrew Feifer; Amit Gupta; William T Lowrance; Michael J Morris; Peter T Scardino; Elena B Elkin
Androgen deprivation and thromboembolic events in men with prostate cancer.
Cancer 2012;118(13):3397-406.
2012: Fred Saad; James A Eastham; Matthew R Smith
Biochemical markers of bone turnover and clinical outcomes in men with prostate cancer.
Urologic oncology 2012;30(4):369-78.
2012: William T Lowrance; Peter T Scardino; David S Yee; Brian Denton; James A Eastham; Vincent Laudone; Elena B Elkin
Costs of medical care after open or minimally invasive prostate cancer surgery: a population-based analysis.
Cancer 2012;118(12):3079-86.
2012: Guilherme Godoy; Peter T Scardino; Christian von Bodman; Daher C Chade; Ozdal Dillioglugil; James A Eastham; Samson W Fine; Vincent Laudone
Pelvic lymph node dissection for prostate cancer: frequency and distribution of nodal metastases in a contemporary radical prostatectomy series.
The Journal of urology 2012;187(6):2082-6.
2012: Jonathan L Silberstein; Karim Touijer; Andrew J Vickers; Jonathan Coleman; James A Eastham; Raul O Parra; Rodrigo Pinochet; Nicholas E Power; Peter T Scardino; Vincent Laudone
Pelvic lymph node dissection for patients with elevated risk of lymph node invasion during radical prostatectomy: comparison of open, laparoscopic and robot-assisted procedures.
Journal of endourology / Endourological Society 2012;26(6):748-53.
2012: Clarisse Mazzola; Victor E Reuter; Caroline Savage; Peter T Scardino; Youness Ahallal; James A Eastham; Bertrand Guillonneau; Karim Touijer
Nodal counts during pelvic lymph node dissection for prostate cancer: an objective indicator of quality under the influence of very subjective factors.
BJU international 2012;109(9):1323-8.
2012: Amita Dave; Kazuma Udo; Changhong Yu; Kristen L Zakian; Oguz Akin; James A Eastham; Hedvig Hricak; Peter T Scardino; Michael W Kattan
Preoperative nomograms incorporating magnetic resonance imaging and spectroscopy for prediction of insignificant prostate cancer.
BJU international 2012;109(9):1315-22.
2012: Joshua J Meeks; James A Eastham
Robotic prostatectomy: the rise of the machines or judgment day.
European urology 2012;61(4):686-7; discussion 688-9.
2012: Christian von Bodman; Caroline Savage; Peter T Scardino; Oguz Akin; James A Eastham; Mika P Matikainen; Kazuhito Matsushita; Farhang Rabbani; Jaspreet S Sandhu
Recovery of urinary function after radical prostatectomy: predictors of urinary function on preoperative prostate magnetic resonance imaging.
The Journal of urology 2012;187(3):945-50.
2012: David J Gallagher; Matthew I Milowsky; Michael J Morris; Kenneth Offit; Jasmine Bhatia; Angel M Cronin; James A Eastham; Peter T Scardino; Mark Robson
Germline BRCA mutation does not prevent response to taxane-based therapy for the treatment of castration-resistant prostate cancer.
BJU international 2012;109(5):713-9.
2012: Andrew J Vickers; Karim Touijer; Caroline Bennette; Brett Carver; Jonathan Coleman; James A Eastham; Vincent Laudone; Peter T Scardino
Feasibility study of a clinically-integrated randomized trial of modifications to radical prostatectomy.
Trials 2012;13():23.
2011: Anuj Goenka; Marisa Kollmeier; Juan Martin Magsanoc; Xin Pei; Peter T Scardino; Michael Schechter; Brett Cox; James A Eastham; Michael J Zelefsky
Improved toxicity profile following high-dose postprostatectomy salvage radiation therapy with intensity-modulated radiation therapy.
European urology 2011;60(6):1142-8.
2011: Jonathan L Silberstein; Andrew J Vickers; James A Eastham; Samson W Fine; Nicholas E Power; Peter T Scardino; Vincent Laudone
Reverse stage shift at a tertiary care center: escalating risk in men undergoing radical prostatectomy.
Cancer 2011;117(21):4855-60.
2011: Andrew H Feifer; Lindsay Jacks; Vincent Laudone; William T Lowrance; Peter T Scardino; David S Yee; Jonathan Coleman; Brian Denton; Elena B Elkin; James A Eastham
Temporal trends and predictors of pelvic lymph node dissection in open or minimally invasive radical prostatectomy.
Cancer 2011;117(17):3933-42.
2011: Daher C Chade; Angel M Cronin; Marcos Dall'Oglio; Michael L Blute; Alberto Briganti; Martin E Gleave; Guilherme Godoy; Antonio Hurtado-coll; Steven Joniau; R Jeffrey Karnes; Francesco Montorsi; Caroline J Savage; Peter T Scardino; Shahrokh F Shariat; Miguel Srougi; Henk G van der Poel; Hendrik Van Poppel; James A Eastham
Salvage radical prostatectomy for radiation-recurrent prostate cancer: a multi-institutional collaboration.
European urology 2011;60(2):205-10.
2011: Guilherme Godoy; Bertrand Guillonneau; Vincent Laudone; Peter T Scardino; Karim Touijer; Andrew Vickers; Kian Tai Chong; Angel Cronin; James A Eastham; Jonathan Coleman
Extent of pelvic lymph node dissection and the impact of standard template dissection on nomogram prediction of lymph node involvement.
European urology 2011;60(2):195-201.
2011: David S Yee; Angel M Cronin; William T Lowrance; Alexandra C Maschino; Caroline J Savage; Peter T Scardino; Shahrokh F Shariat; James A Eastham
Prognostic significance of lymphovascular invasion in radical prostatectomy specimens.
BJU international 2011;108(4):502-7.
2011: Jaspreet S Sandhu; Geoffrey T Gotto; Luis A Herran; Peter T Scardino; James A Eastham; Farhang Rabbani
Age, obesity, medical comorbidities and surgical technique are predictive of symptomatic anastomotic strictures after contemporary radical prostatectomy.
The Journal of urology 2011;185(6):2148-52.
2011: M Frank O'Brien; Angel M Cronin; Paul Fearn; Caroline J Savage; Brandon Smith; Jason Stasi; Peter T Scardino; Gabrielle Fisher; Jack Cuzick; Henrik Møller; R Timothy Oliver; Daniel M Berney; Christopher S Foster; James A Eastham; Andrew J Vickers; Hans Lilja
Evaluation of prediagnostic prostate-specific antigen dynamics as predictors of death from prostate cancer in patients treated conservatively.
International journal of cancer. Journal international du cancer 2011;128(10):2373-81.
2011: James A Eastham; Peter T Scardino
The devil is in the details.
European urology 2011;59(5):708-9; discussion 710-1.
2011: Hans Lilja; Angel M Cronin; Anders Dahlin; Jonas Manjer; Peter M Nilsson; James A Eastham; Anders S Bjartell; Peter T Scardino; David Ulmert; Andrew J Vickers
Prediction of significant prostate cancer diagnosed 20 to 30 years later with a single measure of prostate-specific antigen at or before age 50.
Cancer 2011;117(6):1210-9.
2011: Ari Adamy; David S Yee; Kazuhito Matsushita; Alexandra Maschino; Angel Cronin; Andrew Vickers; Bertrand Guillonneau; Peter T Scardino; James A Eastham
Role of prostate specific antigen and immediate confirmatory biopsy in predicting progression during active surveillance for low risk prostate cancer.
The Journal of urology 2011;185(2):477-82.
2011: Christian von Bodman; Mika P Matikainen; Ricardo L Favaretto; Kazuhito Matsushita; John P Mulhall; James A Eastham; Peter T Scardino; Oguz Akin; Farhang Rabbani
Pelvimetric dimensions do not impact upon nerve sparing or erectile function recovery in patients undergoing radical retropubic prostatectomy.
The journal of sexual medicine 2011;8(2):567-74.
2010: Yuji Tokuda; Lauren J Carlino; Anuradha Gopalan; SK Tickoo; Matthew G Kaag; Bertrand Guillonneau; James A Eastham; Howard I Scher; Peter T Scardino; Victor E Reuter; Samson W Fine
Prostate cancer topography and patterns of lymph node metastasis.
The American journal of surgical pathology 2010;34(12):1862-7.
2010: Kristen L Zakian; Hedvig Hricak; Nicole Ishill; Victor E Reuter; Steven Eberhardt; Chaya S Moskowitz; Amita Dave; Liang Wang; Peter T Scardino; James A Eastham; Jason A Koutcher
An exploratory study of endorectal magnetic resonance imaging and spectroscopy of the prostate as preoperative predictive biomarkers of biochemical relapse after radical prostatectomy.
The Journal of urology 2010;184(6):2320-7.
2010: Farhang Rabbani; Jeffrey Schiff; Michael Piecuch; Luis Herran Yunis; James A Eastham; Peter T Scardino; John P Mulhall
Time course of recovery of erectile function after radical retropubic prostatectomy: does anyone recover after 2 years?
The journal of sexual medicine 2010;7(12):3984-90.
2010: Fred Saad; James A Eastham
Zoledronic Acid improves clinical outcomes when administered before onset of bone pain in patients with prostate cancer.
Urology 2010;76(5):1175-81.
2010: Cyrille Bastide; Caroline Savage; Angel Cronin; Michael J Zelefsky; James A Eastham; Karim Touijer; Peter T Scardino; Bertrand Guillonneau
Location and number of positive surgical margins as prognostic factors of biochemical recurrence after salvage radiation therapy after radical prostatectomy.
BJU international 2010;106(10):1454-7.
2010: James A Eastham; Christopher P Evans; Anthony L Zietman
What is the optimal management of high risk, clinically localized prostate cancer?
Urologic oncology 2010;28(5):557-67.
2010: Mika P Matikainen; Christian J von Bodman; Fernando P Secin; Luis Herran Yunis; Kinjal C Vora; Bertrand Guillonneau; Vincent Laudone; James A Eastham; Peter T Scardino; Oguz Akin; Farhang Rabbani
The depth of the prostatic apex is an independent predictor of positive apical margins at radical prostatectomy.
BJU international 2010;106(5):622-6.
2010: Barry S Taylor; Nikolaus Schultz; Haley Hieronymus; Anuradha Gopalan; Yonghong Xiao; Brett S Carver; Vivek K Arora; Poorvi Kaushik; Ethan Cerami; Boris Reva; Yevgeniy Antipin; Nicholas Mitsiades; Thomas Landers; Igor Dolgalev; John E Major; Manda Wilson; Nicholas D Socci; Alex E Lash; Adriana Heguy; James A Eastham; Howard I Scher; Victor E Reuter; Peter T Scardino; Chris Sander; Charles L Sawyers; William L Gerald
Integrative genomic profiling of human prostate cancer.
Cancer cell 2010;18(1):11-22.
2010: Geoffrey T Gotto; Luis Herran Yunis; Kinjal C Vora; James A Eastham; Peter T Scardino; Farhang Rabbani
Impact of prior prostate radiation on complications after radical prostatectomy.
The Journal of urology 2010;184(1):136-42.
2010: Christian von Bodman; Guilherme Godoy; Daher C Chade; Angel Cronin; Laura J Tafe; Samson W Fine; Vincent Laudone; Peter T Scardino; James A Eastham
Predicting biochemical recurrence-free survival for patients with positive pelvic lymph nodes at radical prostatectomy.
The Journal of urology 2010;184(1):143-8.
2010: Fred Saad; James A Eastham
Zoledronic acid use in patients with bone metastases from renal cell carcinoma or bladder cancer.
Seminars in oncology 2010;37 Suppl 1():S38-44.
2010: Fred Saad; James A Eastham
Maintaining bone health in prostate cancer throughout the disease continuum.
Seminars in oncology 2010;37 Suppl 1():S30-7.
2010: David J Gallagher; Joseph Vijai; Angel M Cronin; Jasmine Bhatia; Andrew J Vickers; Mia M. Gaudet; Samson W Fine; Victor E Reuter; Howard I Scher; Christer Halldén; Ana Dutra-Clarke; Robert J. Klein; Peter T Scardino; James A Eastham; Hans Lilja; Tomas Kirchhoff; Kenneth Offit
Susceptibility loci associated with prostate cancer progression and mortality.
Clinical cancer research : an official journal of the American Association for Cancer Research 2010;16(10):2819-32.
2010: Jaspreet S Sandhu; James A Eastham
Factors predicting early return of continence after radical prostatectomy.
Current urology reports 2010;11(3):191-7.
2010: David J Gallagher; Mia M. Gaudet; Prodipto Pal; Tomas Kirchhoff; Lisa Balistreri; Kinjal Vora; Jasmine Bhatia; Zsofia Kinga Stadler; Samson W Fine; Victor E Reuter; Michael J Zelefsky; Michael J Morris; Howard I Scher; Robert J. Klein; Larry Norton; James A Eastham; Peter T Scardino; Mark Robson; Kenneth Offit
Germline BRCA mutations denote a clinicopathologic subset of prostate cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2010;16(7):2115-21.
2010: William T Lowrance; Elena B Elkin; Lindsay M Jacks; David S Yee; Thomas L Jang; Vincent Laudone; Bertrand D Guillonneau; Peter T Scardino; James A Eastham
Comparative effectiveness of prostate cancer surgical treatments: a population based analysis of postoperative outcomes.
The Journal of urology 2010;183(4):1366-72.
2010: Andrew J Vickers; Angel M Cronin; Timothy A Masterson; James A Eastham
How do you tell whether a change in surgical technique leads to a change in outcome?
The Journal of urology 2010;183(4):1510-4.
2010: Andrew J Vickers; Fernando Bianco; Angel Cronin; James A Eastham; Eric Klein; Michael Kattan; Peter T Scardino
The learning curve for surgical margins after open radical prostatectomy: implications for margin status as an oncological end point.
The Journal of urology 2010;183(4):1360-5.
2010: Michael J Zelefsky; James A Eastham; Angel M Cronin; Zvi Fuks; Zhigang Zhang; Yoshiya Yamada; Andrew J Vickers; Peter T Scardino
Metastasis after radical prostatectomy or external beam radiotherapy for patients with clinically localized prostate cancer: a comparison of clinical cohorts adjusted for case mix.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(9):1508-13.
2010: William T Lowrance; Elena B Elkin; Peter T Scardino; James A Eastham
Words of wisdom. Re: Comparative effectiveness of minimally invasive vs open radical prostatectomy.
European urology 2010;57(3):538.
2010: Fernando J Bianco; Andrew J Vickers; Angel M Cronin; Eric A Klein; James A Eastham; J Edson Pontes; Peter T Scardino
Variations among experienced surgeons in cancer control after open radical prostatectomy.
The Journal of urology 2010;183(3):977-82.
2010: Farhang Rabbani; Luis Herran Yunis; Rodrigo Pinochet; LUCAS NOGUEIRA; Kinjal C Vora; James A Eastham; Bertrand Guillonneau; Vincent Laudone; Peter T Scardino; Karim Touijer
Comprehensive standardized report of complications of retropubic and laparoscopic radical prostatectomy.
European urology 2010;57(3):371-86.
2010: William T Lowrance; Elena B Elkin; James A Eastham
Minimally invasive vs open radical prostatectomy.
JAMA : the journal of the American Medical Association 2010;303(7):619-20; author reply 620.
2010: James Mohler; Robert R Bahnson; Barry Boston; J Erik Busby; Anthony D'Amico; James A Eastham; Charles A Enke; Daniel George; Eric Mark Horwitz; Robert P Huben; Philip Kantoff; Mark Kawachi; Michael Kuettel; Paul H Lange; Gary Macvicar; Elizabeth R Plimack; Julio Pow-Sang; Mack Roach; Eric Rohren; Bruce J Roth; Dennis C Shrieve; Matthew R Smith; Sandy Srinivas; Przemyslaw Twardowski; Patrick C Walsh
NCCN clinical practice guidelines in oncology: prostate cancer.
Journal of the National Comprehensive Cancer Network : JNCCN 2010;8(2):162-200.
2010: Jochen Walz; Arthur L Burnett; Anthony J Costello; James A Eastham; Markus Graefen; Bertrand Guillonneau; Mani Menon; Francesco Montorsi; Robert P Myers; Bernardo Rocco; Arnauld Villers
A critical analysis of the current knowledge of surgical anatomy related to optimization of cancer control and preservation of continence and erection in candidates for radical prostatectomy.
European urology 2010;57(2):179-92.
2010: Darren Katz; Nelson E Bennett; Jason Stasi; James A Eastham; Bertrand Guillonneau; Peter T Scardino; John P Mulhall
Chronology of erectile function in patients with early functional erections following radical prostatectomy.
The journal of sexual medicine 2010;7(2 Pt 1):803-9.
2010: Andrew J Vickers; Caroline J Savage; Marwan Shouery; James A Eastham; Peter T Scardino; Ethan Basch
Validation study of a web-based assessment of functional recovery after radical prostatectomy.
Health and quality of life outcomes 2010;8():82.
2010: Andrew J Vickers; Talya Salz; Ethan Basch; Matthew R Cooperberg; Peter R Carroll; Foss Tighe; James A Eastham; Raymond C Rosen
Electronic patient self-assessment and management (SAM): a novel framework for cancer survivorship.
BMC medical informatics and decision making 2010;10():34.
2010: Jacob H Cohen; James A Eastham; Richard J Macchia
Outcomes following negative prostate biopsy for patients with persistent disease after radiotherapy for prostate cancer.
International braz j urol : official journal of the Brazilian Society of Urology 2010;36(1):44-8.
2010: LUCAS NOGUEIRA; Renato Corradi; James A Eastham
Other biomarkers for detecting prostate cancer.
BJU international 2010;105(2):166-9.
2010: Farhang Rabbani; Ranjith Ramasamy; Manish I Patel; Paul Cozzi; Joseph J Disa; Peter G Cordeiro; Babak J Mehrara; James A Eastham; Peter T Scardino; John P Mulhall
Predictors of recovery of erectile function after unilateral cavernous nerve graft reconstruction at radical retropubic prostatectomy.
The journal of sexual medicine 2010;7(1 Pt 1):166-81.
2010: David S Yee; William T Lowrance; James A Eastham; Alexandra C Maschino; Angel M Cronin; Farhang Rabbani
Long-term follow-up of 3-month neoadjuvant hormone therapy before radical prostatectomy in a randomized trial.
BJU international 2010;105(2):185-90.
2009: Jingbo Zhang; Hedvig Hricak; Amita Dave; Oguz Akin; Nicole Ishill; Lauren J Carlino; Victor E Reuter; James A Eastham
Clinical stage T1c prostate cancer: evaluation with endorectal MR imaging and MR spectroscopic imaging.
Radiology 2009;253(2):425-34.
2009: Andrew J Stephenson; David P Wood Jr; Michael W Kattan; Eric A Klein; Peter T Scardino; James A Eastham; Brett S Carver
Location, extent and number of positive surgical margins do not improve accuracy of predicting prostate cancer recurrence after radical prostatectomy.
The Journal of urology 2009;182(4):1357-63.
2009: Chadwick F Haarer; Anuradha Gopalan; SK Tickoo; Peter T Scardino; James A Eastham; Victor E Reuter; Samson W Fine
Prostatic transition zone directed needle biopsies uncommonly sample clinically relevant transition zone tumors.
The Journal of urology 2009;182(4):1337-41.
2009: Farhang Rabbani; Luis Herran Yunis; Kinjal C Vora; James A Eastham; Bertrand Guillonneau; Peter T Scardino; Karim Touijer
Impact of ethnicity on surgical margins at radical prostatectomy.
BJU international 2009;104(7):904-8.
2009: Andreas Blana; Stephen C W Brown; Christian Chaussy; Giario N Conti; James A Eastham; Roman Ganzer; Francois J Murat; Gilles Pasticier; Xavier Rebillard; John C Rewcastle; Cary N Robertson; Stefan Thuroff; John Ward
High-intensity focused ultrasound for prostate cancer: comparative definitions of biochemical failure.
BJU international 2009;104(8):1058-62.
2009: Andrew J Stephenson; Michael W Kattan; James A Eastham; Fernando J Bianco; Ofer Yossepowitch; Andrew J Vickers; Eric A Klein; David P Wood Jr; Peter T Scardino
Prostate cancer-specific mortality after radical prostatectomy for patients treated in the prostate-specific antigen era.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(26):4300-5.
2009: LUCAS NOGUEIRA; Renato Corradi; James A Eastham
Prostatic specific antigen for prostate cancer detection.
International braz j urol : official journal of the Brazilian Society of Urology 2009;35(5):521-9; discussion 530-2.
2009: Farhang Rabbani; Kinjal C Vora; Luis Herran Yunis; James A Eastham; Bertrand Guillonneau; Peter T Scardino; Karim Touijer
Biochemical recurrence rate in patients with positive surgical margins at radical prostatectomy with further negative resected tissue.
BJU international 2009;104(5):605-10.
2009: Matthew Frank O'Brien; Angel M Cronin; Paul Fearn; Brandon Smith; Jason Stasi; Bertrand Guillonneau; Peter T Scardino; James A Eastham; Andrew J Vickers; Hans Lilja
Pretreatment prostate-specific antigen (PSA) velocity and doubling time are associated with outcome but neither improves prediction of outcome beyond pretreatment PSA alone in patients treated with radical prostatectomy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(22):3591-7.
2009: Timothy A Masterson; Alexei Wedmid; Jaspreet S Sandhu; James A Eastham
Outcomes after radical prostatectomy in men receiving previous pelvic radiation for non-prostate malignancies.
BJU international 2009;104(4):482-5.
2009: Michael Fuchsjäger; Amita Dave; Hedvig Hricak; Liang Wang; Karim Touijer; John F Donohue; James A Eastham; Michael W Kattan
Magnetic resonance imaging in the prediction of biochemical recurrence of prostate cancer after radical prostatectomy.
BJU international 2009;104(3):315-20.
2009: James A Eastham
Do high-volume hospitals and surgeons provide better care in urologic oncology?
Urologic oncology 2009;27(4):417-21.
2009: Sak Kudahetti; Gabrielle Fisher; Laurence Ambroisine; Christopher Foster; Victor E Reuter; James A Eastham; Henrik Møller; Michael W Kattan; Colin S Cooper; Peter T Scardino; Jack Cuzick; Daniel M Berney
p53 immunochemistry is an independent prognostic marker for outcome in conservatively treated prostate cancer.
BJU international 2009;104(1):20-4.
2009: David J Galvin; James A Eastham
Critical appraisal of outcomes following open radical prostatectomy.
Current opinion in urology 2009;19(3):297-302.
2009: Ryan K Berglund; Andrew J Stephenson; Angel M Cronin; Andrew J Vickers; James A Eastham; Eric A Klein; Bertrand Guillonneau
Comparison of observed biochemical recurrence-free survival in patients with low PSA values undergoing radical prostatectomy and predictions of preoperative nomogram.
Urology 2009;73(5):1098-103.
2009: Pauliina Helo; Angel M Cronin; Daniel C Danila; Sven Wenske; Rita Gonzalez-Espinoza; Aseem Anand; Michael Koscuiszka; Riina-Minna Väänänen; Kim Pettersson; Felix K-H Chun; Thomas Steuber; Hartwig Huland; Bertrand D Guillonneau; James A Eastham; Peter T Scardino; Martin Fleisher; Howard I Scher; Hans Lilja
Circulating prostate tumor cells detected by reverse transcription-PCR in men with localized or castration-refractory prostate cancer: concordance with CellSearch assay and association with bone metastases and with survival.
Clinical chemistry 2009;55(4):765-73.
2009: Scott E Eggener; Alex Mueller; Ryan K Berglund; Raj Ayyathurai; Cindy Soloway; Mark S Soloway; Robert Abouassaly; Eric A Klein; Steven J Jones; Chris Zappavigna; Larry Goldenberg; Peter T Scardino; James A Eastham; Bertrand Guillonneau
A multi-institutional evaluation of active surveillance for low risk prostate cancer.
The Journal of urology 2009;181(4):1635-41; discussion 1641.
2009: D M Berney; A Gopalan; S Kudahetti; G Fisher; L Ambroisine; C S Foster; Victor E Reuter; James A Eastham; Henrik Møller; Michael W Kattan; W Gerald; C Cooper; Peter T Scardino; Jack Cuzick
Ki-67 and outcome in clinically localised prostate cancer: analysis of conservatively treated prostate cancer patients from the Trans-Atlantic Prostate Group study.
British journal of cancer 2009;100(6):888-93.
2009: R Houston Thompson; James A Eastham; Peter T Scardino; Joel Sheinfeld
Critical elements in fellowship training.
Urologic oncology 2009;27(2):199-204.
2009: Michael W Kattan; Andrew J Vickers; Changhong Yu; Fernando J Bianco; Angel M Cronin; James A Eastham; Eric A Klein; Alwyn M Reuther; Jose Edson Pontes; Peter T Scardino
Preoperative and postoperative nomograms incorporating surgeon experience for clinically localized prostate cancer.
Cancer 2009;115(5):1005-10.
2009: Anuradha Gopalan; Margaret A Leversha; Jaya M Satagopan; Qin Zhou; Hikmat Al-Ahmadie; Samson W Fine; James A Eastham; Peter T Scardino; Howard I Scher; Satish K Tickoo; Victor E Reuter; William L Gerald
TMPRSS2-ERG gene fusion is not associated with outcome in patients treated by prostatectomy.
Cancer research 2009;69(4):1400-6.
2009: James A Eastham; Yuji Tokuda; Peter T Scardino
Trends in radical prostatectomy.
International journal of urology : official journal of the Japanese Urological Association 2009;16(2):151-60.
2009: Fernando P Secin; Fernando J Bianco; Angel Cronin; James A Eastham; Peter T Scardino; Bertrand Guillonneau; Andrew J Vickers
Is it necessary to remove the seminal vesicles completely at radical prostatectomy? decision curve analysis of European Society of Urologic Oncology criteria.
The Journal of urology 2009;181(2):609-13; discussion 614.
2009: Sven Wenske; Ruslan Korets; Angel M Cronin; Andrew J Vickers; Martin Fleisher; Howard I Scher; Kim Pettersson; Bertrand Guillonneau; Peter T Scardino; James A Eastham; Hans Lilja
Evaluation of molecular forms of prostate-specific antigen and human kallikrein 2 in predicting biochemical failure after radical prostatectomy.
International journal of cancer. Journal international du cancer 2009;124(3):659-63.
2009: Philippe Paparel; Angel M Cronin; Caroline Savage; Peter T Scardino; James A Eastham
Oncologic outcome and patterns of recurrence after salvage radical prostatectomy.
European urology 2009;55(2):404-10.
2009: James A Eastham
Words of wisdom. Re: Prostate cancer-specific survival following salvage radiotherapy versus observation in men with biochemical recurrence after radical prostatectomy. Trock BJ, Han M, Freedland SJ, Humphreys EB, DeWeese TL, Partin AW, Walsh PC. JAMA 2008;299:2760-9.
European urology 2009;55(1):247.
2009: Stephen J Freedland; James A Eastham; N Shore
Androgen deprivation therapy and estrogen deficiency induced adverse effects in the treatment of prostate cancer.
Prostate cancer and prostatic diseases 2009;12(4):333-8.
2009: Ofer Yossepowitch; Anders Bjartell; James A Eastham; Markus Graefen; Bertrand D Guillonneau; Pierre I Karakiewicz; Rodolfo Montironi; Franceso Montorsi
Positive surgical margins in radical prostatectomy: outlining the problem and its long-term consequences.
European urology 2009;55(1):87-99.
2008: Ryan K Berglund; Timothy A Masterson; Kinjal C Vora; Scott E Eggener; James A Eastham; Bertrand Guillonneau
Pathological upgrading and up staging with immediate repeat biopsy in patients eligible for active surveillance.
The Journal of urology 2008;180(5):1964-7; discussion 1967-8.
2008: James A Eastham
Robotic-assisted prostatectomy: is there truth in advertising?
European urology 2008;54(4):720-2.
2008: Atreya Dash; Peng Lee (Li); Qin Zhou; Jerome Jean-Gilles; Samir Taneja; Jaya M Satagopan; Victor E Reuter; William Gerald; James A Eastham; Iman Osman
Impact of socioeconomic factors on prostate cancer outcomes in black patients treated with surgery.
Urology 2008;72(3):641-6.
2008: Scott A Tomlins; Daniel R Rhodes; Jianjun Yu; Sooryanarayana Lnu; Rohit Mehra; Sven Perner; Francesca Demichelis; Beth E Helgeson; Bharathi Laxman; David S Morris; Qi Cao; Xuhong Cao; Ove Andrén; Katja Fall; Laura Johnson; John T Wei; Rajal B Shah; Hikmat Al-Ahmadie; James A Eastham; Scott E Eggener; Samson W Fine; Kristina Hotakainen; Ulf-Hakan Stenman; Alex Tsodikov; William L Gerald; Hans Lilja; Victor E Reuter; Philip W Kantoff; Peter T Scardino; Mark A Rubin; Anders S Bjartell; Arul M Chinnaiyan
The role of SPINK1 in ETS rearrangement-negative prostate cancers.
Cancer cell 2008;13(6):519-28.
2008: Eric A Klein; Fernando J Bianco; Angel M Serio; James A Eastham; Michael W Kattan; J Edson Pontes; Andrew J Vickers; Peter T Scardino
Surgeon experience is strongly associated with biochemical recurrence after radical prostatectomy for all preoperative risk categories.
The Journal of urology 2008;179(6):2212-6; discussion 2216-7.
2008: James A Eastham; Peter T Scardino; Michael W Kattan
Predicting an optimal outcome after radical prostatectomy: the trifecta nomogram.
The Journal of urology 2008;179(6):2207-10; discussion 2210-1.
2008: Andrea Gallina; Felix K-H Chun; Nazareno Suardi; James A Eastham; Paul Perrotte; Markus Graefen; Georg C Hutterer; Hartwig Huland; Eric A Klein; Alwyn M Reuther; Francesco Montorsi; Alberto Briganti; Shahrokh F Shariat; Claus G Roehrborn; Alexandre de la Taille; Laurent Salomon; Pierre I Karakiewicz
Comparison of stage migration patterns between Europe and the USA: an analysis of 11 350 men treated with radical prostatectomy for prostate cancer.
BJU international 2008;101(12):1513-8.
2008: Ofer Yossepowitch; James A Eastham
Radical prostatectomy for high-risk prostate cancer.
World journal of urology 2008;26(3):219-24.
2008: James A Eastham
Editorial comment on: first analysis of the long-term results with transrectal HIFU in patients with localized prostate cancer.
European urology 2008;53(6):1202-3.
2008: Ofer Yossepowitch; James A Eastham
Role of radical prostatectomy in the treatment of high-risk prostate cancer.
Current urology reports 2008;9(3):203-10.
2008: Peter Swindle; James A Eastham; Makoto Ohori; Michael W Kattan; Thomas Wheeler; Norio Maru; Kevin Slawin; Peter T Scardino
Do margins matter? The prognostic significance of positive surgical margins in radical prostatectomy specimens.
The Journal of urology 2008;179(5 Suppl):S47-51.
2008: Karim Touijer; James A Eastham; Fernando P Secin; Javier Romero Otero; Angel M Serio; Jason Stasi; Rafael Sanchez Salas; Andrew J Vickers; Victor E Reuter; Peter T Scardino; Bertrand Guillonneau
Comprehensive prospective comparative analysis of outcomes between open and laparoscopic radical prostatectomy conducted in 2003 to 2005.
The Journal of urology 2008;179(5):1811-7; discussion 1817.
2008: Timothy A Masterson; Angel M Serio; John P Mulhall; Andrew J Vickers; James A Eastham
Modified technique for neurovascular bundle preservation during radical prostatectomy: association between technique and recovery of erectile function.
BJU international 2008;101(10):1217-22.
2008: Andrew J Vickers; Fernando J Bianco; Mithat Gonen; Angel M Cronin; James A Eastham; Deborah Schrag; Eric A Klein; Alwyn M Reuther; Michael W Kattan; J Edson Pontes; Peter T Scardino
Effects of pathologic stage on the learning curve for radical prostatectomy: evidence that recurrence in organ-confined cancer is largely related to inadequate surgical technique.
European urology 2008;53(5):960-6.
2008: Ofer Yossepowitch; Scott E Eggener; Angel M Serio; Brett S Carver; Fernando J Bianco; Peter T Scardino; James A Eastham
Secondary therapy, metastatic progression, and cancer-specific mortality in men with clinically high-risk prostate cancer treated with radical prostatectomy.
European urology 2008;53(5):950-9.
2008: Lee Richstone; Fernando J Bianco; Hiral H Shah; Michael W Kattan; James A Eastham; Peter T Scardino; Douglas Scherr
Radical prostatectomy in men aged >or=70 years: effect of age on upgrading, upstaging, and the accuracy of a preoperative nomogram.
BJU international 2008;101(5):541-6.
2008: David Ulmert; Angel M Serio; Matthew F O'Brien; Charlotte Becker; James A Eastham; Peter T Scardino; Thomas Björk; Göran Berglund; Andrew J Vickers; Hans Lilja
Long-term prediction of prostate cancer: prostate-specific antigen (PSA) velocity is predictive but does not improve the predictive accuracy of a single PSA measurement 15 years or more before cancer diagnosis in a large, representative, unscreened population.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(6):835-41.
2008: James A Eastham; Michael W Kattan; Paul Fearn; Gabrielle Fisher; Daniel M Berney; Tim Oliver; Christopher S Foster; Henrik Møller; Victor E Reuter; Jack Cuzick; Peter T Scardino
Local progression among men with conservatively treated localized prostate cancer: results from the Transatlantic Prostate Group.
European urology 2008;53(2):347-54.
2008: David Ulmert; Angel M Cronin; Thomas Björk; Matthew F O'Brien; Peter T Scardino; James A Eastham; Charlotte Becker; Göran Berglund; Andrew J Vickers; Hans Lilja
Prostate-specific antigen at or before age 50 as a predictor of advanced prostate cancer diagnosed up to 25 years later: a case-control study.
BMC medicine 2008;6():6.
2008: Michael W Kattan; Jack Cuzick; Gabrielle Fisher; Daniel M Berney; Tim Oliver; Christopher S Foster; Henrik Møller; Victor E Reuter; Paul Fearn; James A Eastham; Peter T Scardino
Nomogram incorporating PSA level to predict cancer-specific survival for men with clinically localized prostate cancer managed without curative intent.
Cancer 2008;112(1):69-74.
2007: Xingxing Zang; R Houston Thompson; Hikmat Al-Ahmadie; Angel M Serio; Victor E Reuter; James A Eastham; Peter T Scardino; Padmanee Sharma; James P Allison
B7-H3 and B7x are highly expressed in human prostate cancer and associated with disease spread and poor outcome.
Proceedings of the National Academy of Sciences of the United States of America 2007;104(49):19458-63.
2007: Daniel M Berney; Gabrielle Fisher; Michael W Kattan; R T D Oliver; Henrik Møller; Paul Fearn; James A Eastham; Peter T Scardino; Jack Cuzick; Victor E Reuter; Christopher S Foster
Major shifts in the treatment and prognosis of prostate cancer due to changes in pathological diagnosis and grading.
BJU international 2007;100(6):1240-4.
2007: Andrew J Vickers; David Ulmert; Angel M Serio; Thomas Björk; Peter T Scardino; James A Eastham; Göran Berglund; Hans Lilja
The predictive value of prostate cancer biomarkers depends on age and time to diagnosis: towards a biologically-based screening strategy.
International journal of cancer. Journal international du cancer 2007;121(10):2212-7.
2007: James A Eastham; Kentaro Kuroiwa; Makoto Ohori; Angel M Serio; Alex Gorbonos; Norio Maru; Andrew J Vickers; Kevin Slawin; Thomas M Wheeler; Victor E Reuter; Peter T Scardino
Prognostic significance of location of positive margins in radical prostatectomy specimens.
Urology 2007;70(5):965-9.
2007: James A Eastham
Surgery Insight: optimizing open nerve-sparing radical prostatectomy techniques for improved outcomes.
Nature clinical practice. Urology 2007;4(10):561-9.
2007: Daniel M Berney; Gabrielle Fisher; Michael W Kattan; R T D Oliver; Henrik Møller; Paul Fearn; James A Eastham; Peter T Scardino; Jack Cuzick; Victor E Reuter; Christopher S Foster
Pitfalls in the diagnosis of prostatic cancer: retrospective review of 1791 cases with clinical outcome.
Histopathology 2007;51(4):452-7.
2007: Karim Touijer; Kentaro Kuroiwa; James A Eastham; Andrew J Vickers; Victor E Reuter; Peter T Scardino; Bertrand Guillonneau
Risk-adjusted analysis of positive surgical margins following laparoscopic and retropubic radical prostatectomy.
European urology 2007;52(4):1090-6.
2007: Darko Pucar; Hedvig Hricak; Amita Dave; Kentaro Kuroiwa; Marija Drobnjak; James A Eastham; Peter T Scardino; Michael J Zelefsky
Clinically significant prostate cancer local recurrence after radiation therapy occurs at the site of primary tumor: magnetic resonance imaging and step-section pathology evidence.
International journal of radiation oncology, biology, physics 2007;69(1):62-9.
2007: James Mohler; Richard J Babaian; Robert R Bahnson; Barry Boston; Anthony V D'Amico; James A Eastham; Ralph J Hauke; Robert P Huben; Philip W Kantoff; Mark Kawachi; Michael Kuettel; Paul H Lange; Chris Logothetis; Gary MacVicar; Alan Pollack; Julio Pow-Sang; Mack Roach; Howard Sandler; Dennis C Shrieve; Sandhya Srinivas; Przemyslaw Twardowski; Donald A Urban; Patrick C Walsh
Prostate cancer. Clinical practice guidelines in oncology.
Journal of the National Comprehensive Cancer Network : JNCCN 2007;5(7):650-83.
2007: Jennifer R Hill; Samson W Fine; Jingbo Zhang; James A Eastham
Radical prostatectomy for clinical T3 disease: expanding indications while optimizing cancer control and quality of life.
Nature clinical practice. Urology 2007;4(8):451-4.
2007: Andrew J Vickers; Fernando J Bianco; Angel M Serio; James A Eastham; Deborah Schrag; Eric A Klein; Alwyn M Reuther; Michael W Kattan; J Edson Pontes; Peter T Scardino
The surgical learning curve for prostate cancer control after radical prostatectomy.
Journal of the National Cancer Institute 2007;99(15):1171-7.
2007: Ofer Yossepowitch; Scott E Eggener; Fernando J Bianco; Brett S Carver; Angel M Serio; Peter T Scardino; James A Eastham
Radical prostatectomy for clinically localized, high risk prostate cancer: critical analysis of risk assessment methods.
The Journal of urology 2007;178(2):493-9; discussion 499.
2007: Anders Bjartell; Hikmat Al-Ahmadie; Angel M Serio; James A Eastham; Scott E Eggener; Samson W Fine; Lene Udby; William L Gerald; Andrew J Vickers; Hans Lilja; Victor E Reuter; Peter T Scardino
Association of cysteine-rich secretory protein 3 and beta-microseminoprotein with outcome after radical prostatectomy.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(14):4130-8.
2007: Karim Touijer; Farhang Rabbani; Javier Romero Otero; Fernando P Secin; James A Eastham; Peter T Scardino; Bertrand Guillonneau
Standard versus limited pelvic lymph node dissection for prostate cancer in patients with a predicted probability of nodal metastasis greater than 1%.
The Journal of urology 2007;178(1):120-4.
2007: Scott E Eggener; Ofer Yossepowitch; Angel M Serio; Andrew J Vickers; Peter T Scardino; James A Eastham
Radical prostatectomy shortly after prostate biopsy does not affect operative difficulty or efficacy.
Urology 2007;69(6):1128-33.
2007: William C Huang; Courtney L Lee; James A Eastham
Locally ablative therapies for primary radiation failures: a review and critical assessment of the efficacy.
Current urology reports 2007;8(3):217-23.
2007: William C Huang; Kentaro Kuroiwa; Angel M Serio; Fernando J Bianco; Samson W Fine; Bobby Shayegan; Peter T Scardino; James A Eastham
The anatomical and pathological characteristics of irradiated prostate cancers may influence the oncological efficacy of salvage ablative therapies.
The Journal of urology 2007;177(4):1324-9; quiz 1591.
2007: Thomas Steuber; Andrew J Vickers; Alexander Haese; Michael W Kattan; James A Eastham; Peter T Scardino; Hartwig Huland; Hans Lilja
Free PSA isoforms and intact and cleaved forms of urokinase plasminogen activator receptor in serum improve selection of patients for prostate cancer biopsy.
International journal of cancer. Journal international du cancer 2007;120(7):1499-504.
2007: Ofer Yossepowitch; Fernando J Bianco; Scott E Eggener; James A Eastham; Howard I Scher; Peter T Scardino
The natural history of noncastrate metastatic prostate cancer after radical prostatectomy.
European urology 2007;51(4):940-7; discussion 947-8.
2007: James A Eastham
Does neurovascular bundle preservation at the time of radical prostatectomy improve urinary continence?
Nature clinical practice. Urology 2007;4(3):138-9.
2007: Fernando P Secin; Theresa Koppie; Peter T Scardino; James A Eastham; Manish Patel; Fernando J Bianco; Raanan Tal; John P Mulhall; Joseph J Disa; Peter G Cordeiro; Farhang Rabbani
Bilateral cavernous nerve interposition grafting during radical retropubic prostatectomy: Memorial Sloan-Kettering Cancer Center experience.
The Journal of urology 2007;177(2):664-8.
2007: Thomas Steuber; Andrew J Vickers; Angel M Serio; Ville Vaisanen; Alexander Haese; Kim Pettersson; James A Eastham; Peter T Scardino; Hartwig Huland; Hans Lilja
Comparison of free and total forms of serum human kallikrein 2 and prostate-specific antigen for prediction of locally advanced and recurrent prostate cancer.
Clinical chemistry 2007;53(2):233-40.
2007: Theresa A Guise; Michael G Oefelein; James A Eastham; Michael S Cookson; Celestia S Higano; Matthew Raymond Smith
Estrogenic side effects of androgen deprivation therapy.
Reviews in urology 2007;9(4):163-80.
2007: James A Eastham
Bone health in men receiving androgen deprivation therapy for prostate cancer.
The Journal of urology 2007;177(1):17-24.
2006: Theresa Koppie; Fernando J Bianco; Kentaro Kuroiwa; Victor E Reuter; Bertrand Guillonneau; James A Eastham; Peter T Scardino
The clinical features of anterior prostate cancers.
BJU international 2006;98(6):1167-71.
2006: Jack Cuzick; Gabrielle Fisher; Michael W Kattan; Daniel M Berney; T Oliver; Christopher S Foster; Henrik Møller; Victor E Reuter; Paul Fearn; James A Eastham; Peter T Scardino
Long-term outcome among men with conservatively treated localised prostate cancer.
British journal of cancer 2006;95(9):1186-94.
2006: Brent V Yanke; Brett S Carver; Fernando J Bianco; Walter J Simoneaux; Dennis D Venable; Isaac J Powell; James A Eastham
African-American race is a predictor of prostate cancer detection: incorporation into a pre-biopsy nomogram.
BJU international 2006;98(4):783-7.
2006: John F Donohue; Fernando J Bianco; Kentaro Kuroiwa; Andrew J Vickers; Thomas M Wheeler; Peter T Scardino; Victor A Reuter; James A Eastham
Poorly differentiated prostate cancer treated with radical prostatectomy: long-term outcome and incidence of pathological downgrading.
The Journal of urology 2006;176(3):991-5.
2006: Andrew J Stephenson; Michael W Kattan; James A Eastham; Zohar A Dotan; Fernando J Bianco; Hans Lilja; Peter T Scardino
Defining biochemical recurrence of prostate cancer after radical prostatectomy: a proposal for a standardized definition.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(24):3973-8.
2006: William C Huang; Eric O Kwon; Peter T Scardino; James A Eastham
Radical prostatectomy in patients infected with human immunodeficiency virus.
BJU international 2006;98(2):303-7.
2006: Brett S Carver; Fernando J Bianco; Peter T Scardino; James A Eastham
Long-term outcome following radical prostatectomy in men with clinical stage T3 prostate cancer.
The Journal of urology 2006;176(2):564-8.
2006: Yoshiya Yamada; Sudershan Bhatia; Marco Zaider; Gilad Cohen; S Machele Donat; James A Eastham; Farhang Rabbani; Karen Schupak; James Lee; Boris Mueller; Michael J Zelefsky
Favorable clinical outcomes of three-dimensional computer-optimized high-dose-rate prostate brachytherapy in the management of localized prostate cancer.
Brachytherapy 2006;5(3):157-64.
2006: Fernando P Secin; Fernando J Bianco; Andrew J Vickers; Victor E Reuter; Thomas Wheeler; Paul Fearn; James A Eastham; Peter T Scardino
Cancer-specific survival and predictors of prostate-specific antigen recurrence and survival in patients with seminal vesicle invasion after radical prostatectomy.
Cancer 2006;106(11):2369-75.
2006: Andrew J Stephenson; Peter T Scardino; James A Eastham; Fernando J Bianco; Zohar A Dotan; Paul Fearn; Michael W Kattan
Preoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy.
Journal of the National Cancer Institute 2006;98(10):715-7.
2006: Timothy A Masterson; Fernando J Bianco; Andrew J Vickers; Christopher J DiBlasio; Paul Fearn; Farhang Rabbani; James A Eastham; Peter T Scardino
The association between total and positive lymph node counts, and disease progression in clinically localized prostate cancer.
The Journal of urology 2006;175(4):1320-4; discussion 1324-5.
2006: Ernesto Lopez-Corona; Makoto Ohori; Thomas M Wheeler; Victor E Reuter; Peter T Scardino; Michael W Kattan; James A Eastham
Prostate cancer diagnosed after repeat biopsies have a favorable pathological outcome but similar recurrence rate.
The Journal of urology 2006;175(3 Pt 1):923-7; discussion 927-8.
2006: Thomas Steuber; Andrew J Vickers; Alexander Haese; Charlotte Becker; Kim Pettersson; Felix K-H Chun; Michael W Kattan; James A Eastham; Peter T Scardino; Hartwig Huland; Hans Lilja
Risk assessment for biochemical recurrence prior to radical prostatectomy: significant enhancement contributed by human glandular kallikrein 2 (hK2) and free prostate specific antigen (PSA) in men with moderate PSA-elevation in serum.
International journal of cancer. Journal international du cancer 2006;118(5):1234-40.
2006: Andrew J Vickers; Fernando J Bianco; Stephen A Boorjian; Peter T Scardino; James A Eastham
Does a delay between diagnosis and radical prostatectomy increase the risk of disease recurrence?
Cancer 2006;106(3):576-80.
2006: Fred Saad; James McKiernan; James A Eastham
Rationale for zoledronic acid therapy in men with hormone-sensitive prostate cancer with or without bone metastasis.
Urologic oncology 2006;24(1):4-12.
2006: Evis Sala; Steven C Eberhardt; Oguz Akin; Chaya S Moskowitz; Chinyere N Onyebuchi; Kentaro Kuroiwa; Nicole Ishill; Michael J Zelefsky; James A Eastham; Hedvig Hricak
Endorectal MR imaging before salvage prostatectomy: tumor localization and staging.
Radiology 2006;238(1):176-83.
2005: Toshiki Tsuboi; Makoto Ohori; Kentaro Kuroiwa; Victor E Reuter; Michael W Kattan; James A Eastham; Peter T Scardino
Is intraoperative frozen section analysis an efficient way to reduce positive surgical margins?
Urology 2005;66(6):1287-91.
2005: Pierre I Karakiewicz; James A Eastham; Markus Graefen; Ilias Cagiannos; Phillip D Stricker; Eric Klein; Thomas Cangiano; Fritz H Schröder; Peter T Scardino; Michael W Kattan
Prognostic impact of positive surgical margins in surgically treated prostate cancer: multi-institutional assessment of 5831 patients.
Urology 2005;66(6):1245-50.
2005: Andrew J Stephenson; James A Eastham
Role of salvage radical prostatectomy for recurrent prostate cancer after radiation therapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(32):8198-203.
2005: Fernando J Bianco; Peter T Scardino; James A Eastham
Radical prostatectomy: long-term cancer control and recovery of sexual and urinary function ("trifecta").
Urology 2005;66(5 Suppl):83-94.
2005: James A Eastham
Prostate-specific antigen doubling time as a prognostic marker in prostate cancer.
Nature clinical practice. Urology 2005;2(10):482-91.
2005: Caleb B Bozeman; Brett S Carver; Gloria Caldito; Dennis D Venable; James A Eastham
Prostate cancer in patients with an abnormal digital rectal examination and serum prostate-specific antigen less than 4.0 ng/mL.
Urology 2005;66(4):803-7.
2005: Andrew J Stephenson; Peter T Scardino; James A Eastham; Fernando J Bianco; Zohar A Dotan; Christopher J DiBlasio; Alwyn M Reuther; Eric A Klein; Michael W Kattan
Postoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(28):7005-12.
2005: Stephen A Boorjian; Fernando J Bianco; Peter T Scardino; James A Eastham
Does the time from biopsy to surgery affect biochemical recurrence after radical prostatectomy?
BJU international 2005;96(6):773-6.
2005: Timothy A Masterson; Andrew J Stephenson; Peter T Scardino; James A Eastham
Recovery of erectile function after salvage radical prostatectomy for locally recurrent prostate cancer after radiotherapy.
Urology 2005;66(3):623-6.
2005: Peter Swindle; James A Eastham; Makoto Ohori; Michael W Kattan; Thomas Wheeler; Norio Maru; Kevin Slawin; Peter T Scardino
Do margins matter? The prognostic significance of positive surgical margins in radical prostatectomy specimens.
The Journal of urology 2005;174(3):903-7.
2005: Jeffery W Saranchuk; Michael W Kattan; Elena B Elkin; A Karim Touijer; Peter T Scardino; James A Eastham
Achieving optimal outcomes after radical prostatectomy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(18):4146-51.
2005: James A Eastham
Active surveillance for prostate cancer with selective delayed definitive therapy.
Clinical prostate cancer 2005;4(1):45-9.
2005: Fernando J Bianco; Peter T Scardino; Andrew J Stephenson; Christopher J DiBlasio; Paul Fearn; James A Eastham
Long-term oncologic results of salvage radical prostatectomy for locally recurrent prostate cancer after radiotherapy.
International journal of radiation oncology, biology, physics 2005;62(2):448-53.
2005: Ginger Isom-Batz; Fernando J Bianco; Michael W Kattan; John P Mulhall; Hans Lilja; James A Eastham
Testosterone as a predictor of pathological stage in clinically localized prostate cancer.
The Journal of urology 2005;173(6):1935-7.
2005: Zohar A Dotan; Fernando J Bianco; Farhang Rabbani; James A Eastham; Paul Fearn; Howard I Scher; Kevin W Kelly; Hui-Ni Chen; Heiko Schöder; Hedvig Hricak; Peter T Scardino; Michael W Kattan
Pattern of prostate-specific antigen (PSA) failure dictates the probability of a positive bone scan in patients with an increasing PSA after radical prostatectomy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(9):1962-8.
2005: Brett S Carver; Michael W Kattan; Peter T Scardino; James A Eastham
Gleason grade remains an important prognostic predictor in men diagnosed with prostate cancer while on finasteride therapy.
BJU international 2005;95(4):509-12.
2004: William D Figg; Michael E Franks; David Venzon; Paul H Duray; Michael C Cox; W Marston Linehan; W Van Bingham; James A Eastham; Eddie Reed; Oliver Sartor
Gleason score and pretreatment prostate-specific antigen in survival among patients with stage D2 prostate cancer.
World journal of urology 2004;22(6):425-30.
2004: Andrew J Stephenson; Peter T Scardino; Fernando J Bianco; Christopher J DiBlasio; Paul Fearn; James A Eastham
Morbidity and functional outcomes of salvage radical prostatectomy for locally recurrent prostate cancer after radiation therapy.
The Journal of urology 2004;172(6 Pt 1):2239-43.
2004: Brett S Carver; Caleb B Bozeman; Walter J Simoneaux; Dennis D Venable; Michael W Kattan; James A Eastham
Race is not a predictor of prostate cancer detection on repeat prostate biopsy.
The Journal of urology 2004;172(5 Pt 1):1853-5.
2004: Andrew J Stephenson; Peter T Scardino; Fernando J Bianco; James A Eastham
Salvage therapy for locally recurrent prostate cancer after external beam radiotherapy.
Current treatment options in oncology 2004;5(5):357-65.
2004: Fernando P Secin; Brett S Carver; Michael W Kattan; James A Eastham
Current recommendations for delaying renal transplantation after localized prostate cancer treatment: are they still appropriate?
Transplantation 2004;78(5):710-2.
2004: Badrinath R Konety; James A Eastham; Victor E Reuter; Peter T Scardino; S Machele Donat; Guido Dalbagni; Paul Russo; Harry W Herr; Lawrence H Schwartz; Philip W Kantoff; Howard I Scher; W Kevin Kelly
Feasibility of radical prostatectomy after neoadjuvant chemohormonal therapy for patients with high risk or locally advanced prostate cancer: results of a phase I/II study.
The Journal of urology 2004;171(2 Pt 1):709-13.
2004: Brett S Carver; Caleb B Bozeman; Dennis D Venable; James A Eastham
Do concerns about more advanced pathological features increase the likelihood of neurovascular bundle resection in black men undergoing radical prostatectomy?
The Journal of urology 2004;171(2 Pt 1):700-2.
2004: Ilias Cagiannos; Pierre I Karakiewicz; Markus Graefen; James A Eastham; Makoto Ohori; Farhang Rabbani; Victor E Reuter; Thomas Wheeler; Patrick A Kupelian; Eric Klein; Hartwig Huland; Peter Hammerer; Andreas Erbersdobler; Fritz Schroeder; Mark F Wildhagen; David I Quinn; Susan M Henshall; John J Grygiel; Robert L Sutherland; Phillip D Stricker; Christopher G Morash; Peter T Scardino; Michael W Kattan
Is year of radical prostatectomy a predictor of outcome in prostate cancer?
The Journal of urology 2004;171(2 Pt 1):692-6.
2004: James A Eastham
Multimodal treatment strategies combining neoadjuvant hormonal therapy and/or chemotherapy with radical prostatectomy in high-risk localised prostate cancer.
Expert opinion on investigational drugs 2004;13(1):39-46.
2003: James A Eastham; W Kevin Kelly; Gary D Grossfeld; Eric J Small
Cancer and Leukemia Group B (CALGB) 90203: a randomized phase 3 study of radical prostatectomy alone versus estramustine and docetaxel before radical prostatectomy for patients with high-risk localized disease.
Urology 2003;62 Suppl 1():55-62.
2003: James A Eastham; Michael W Kattan; Elyn Riedel; Colin B Begg; Thomas M Wheeler; Claudia Gerigk; Mithat Gonen; Victor E Reuter; Peter T Scardino
Variations among individual surgeons in the rate of positive surgical margins in radical prostatectomy specimens.
The Journal of urology 2003;170(6 Pt 1):2292-5.
2003: James A Eastham
High-risk localised prostate cancer: multimodal treatment strategies combining neoadjuvant hormonal therapy and/or chemotherapy with radical prostatectomy.
Expert opinion on emerging drugs 2003;8(2):291-5.
2003: Ilias Cagiannos; Pierre I Karakiewicz; James A Eastham; Makoto Ohori; Farhang Rabbani; Claudia Gerigk; Victor E Reuter; Markus Graefen; Peter Hammerer; Andreas Erbersdobler; Hartwig Huland; Patrick A Kupelian; Eric Klein; David I Quinn; Susan M Henshall; John J Grygiel; Robert L Sutherland; Phillip D Stricker; Christopher G Morash; Peter T Scardino; Michael W Kattan
A preoperative nomogram identifying decreased risk of positive pelvic lymph nodes in patients with prostate cancer.
The Journal of urology 2003;170(5):1798-803.
2003: Michael W Kattan; James A Eastham; Thomas M Wheeler; Norio Maru; Peter T Scardino; Andreas Erbersdobler; Markus Graefen; Hartwig Huland; Hideshige Koh; Shahrokh F Shariat; Kevin Slawin; Makoto Ohori
Counseling men with prostate cancer: a nomogram for predicting the presence of small, moderately differentiated, confined tumors.
The Journal of urology 2003;170(5):1792-7.
2003: James A Eastham; Elyn Riedel; Lianne Latkany; Martin Fleisher; Arthur Schatzkin; Elaine Lanza; Moshe Shike
Dietary manipulation, ethnicity, and serum PSA levels.
Urology 2003;62(4):677-82.
2003: Michael Aleman; Pierre I Karakiewicz; Patrick A Kupelian; Michael W Kattan; Markus Graefen; Ilias Cagiannos; James A Eastham; Peter T Scardino; Hartwig Huland; Eric A Klein
Age and PSA predict likelihood of organ-confined disease in men presenting with PSA less than 10 ng/mL: implications for screening.
Urology 2003;62(1):70-4.
2003: Matthew R Smith; James A Eastham; Donald M Gleason; Daniel Shasha; Simon Tchekmedyian; Norman Zinner
Randomized controlled trial of zoledronic acid to prevent bone loss in men receiving androgen deprivation therapy for nonmetastatic prostate cancer.
The Journal of urology 2003;169(6):2008-12.
2003: James A Eastham; Christopher J DiBlasio; Peter T Scardino
Salvage radical prostatectomy for recurrence of prostate cancer after radiation therapy.
Current urology reports 2003;4(3):211-5.
2003: James A Eastham; Elyn Riedel; Peter T Scardino; Moshe Shike; Martin Fleisher; Arthur Schatzkin; Elaine Lanza; Lianne Latkany; Colin B Begg
Variation of serum prostate-specific antigen levels: an evaluation of year-to-year fluctuations.
JAMA : the journal of the American Medical Association 2003;289(20):2695-700.
2003: Michael W Kattan; James A Eastham
Algorithms for prostate-specific antigen recurrence after treatment of localized prostate cancer.
Clinical prostate cancer 2003;1(4):221-6.
2002: Brett S Carver; John A Mata; Dennis D Venable; James A Eastham
Squamous cell carcinoma of the penis: a retrospective review of forty-five patients in northwest Louisiana.
Southern medical journal 2002;95(8):822-5.
2002: Markus Graefen; Pierre I Karakiewicz; Ilias Cagiannos; David I Quinn; Susan M Henshall; John J Grygiel; Robert L Sutherland; Phillip D Stricker; Eric Klein; Patrick A Kupelian; Donald G Skinner; Gary Lieskovsky; Bernard H Bochner; Hartwig Huland; Peter Hammerer; Alexander Haese; Andreas Erbersdobler; James A Eastham; Jean de Kernion; Thomas Cangiano; Fritz H Schröder; Mark F Wildhagen; Theo Van der Kwast; Peter T Scardino; Michael W Kattan
International validation of a preoperative nomogram for prostate cancer recurrence after radical prostatectomy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(15):3206-12.
2002: James A Eastham; Michael W Kattan; Peter T Scardino
Nomograms as predictive models.
Seminars in urologic oncology 2002;20(2):108-15.
2002: Ilias Cagiannos; Markus Graefen; Pierre I Karakiewicz; Makoto Ohori; James A Eastham; Farhang Rabbani; William Fair; Thomas M Wheeler; Peter Hammerer; Alexander Haese; Andreas Erbersdobler; Hartwig Huland; Peter T Scardino; Michael W Kattan
Analysis of clinical stage T2 prostate cancer: do current subclassifications represent an improvement?
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(8):2025-30.
2002: Brett S Carver; Dennis D Venable; James A Eastham
Large granular cell tumor of the penis in a 53-year-old man with coexisting prostate cancer.
Urology 2002;59(4):602.
2002: Caleb B Bozeman; Brett S Carver; James A Eastham; Dennis D Venable
Treatment of chronic prostatitis lowers serum prostate specific antigen.
The Journal of urology 2002;167(4):1723-6.
2002: James A Eastham; Brett S Carver; Jared Katz; Michael W Kattan
Clinical stage T1c prostate cancer: pathologic outcomes following radical prostatectomy in black and white men.
The Prostate 2002;50(4):236-40.
2002: Douglas Scherr; James A Eastham; Makoto Ohori; Peter T Scardino
Prostate biopsy techniques and indications: when, where, and how?
Seminars in urologic oncology 2002;20(1):18-31.
2001: James A Eastham; Peter T Scardino
Early diagnosis and treatment of prostate cancer.
Disease-a-month : DM 2001;47(9):421-59.
2001: Brett S Carver; G B Zibari; Dennis D Venable; James A Eastham
Renal cell carcinoma detected in a cadaveric donor after orthotopic liver and contralateral renal transplantation in two recipients: four-year follow-up.
Transplantation 2001;71(9):1348-9.
2001: James A Eastham; O Sartor; W Richey; B Moparty; J Sullivan
Racial variation in prostate specific antigen in a large cohort of men without prostate cancer.
The Journal of the Louisiana State Medical Society : official organ of the Louisiana State Medical Society 2001;153(4):184-9.
2001: William S Kubricht; BJ Williams; James A Eastham; Dennis D Venable
Tensile strength of cadaveric fascia lata compared to small intestinal submucosa using suture pull through analysis.
The Journal of urology 2001;165(2):486-90.
2000: James A Eastham; W Grafton; C M Martin; B J Williams
Suppression of primary tumor growth and the progression to metastasis with p53 adenovirus in human prostate cancer.
The Journal of urology 2000;164(3 Pt 1):814-9.
2000: E J Small; D Lew; Bruce G Redman; Daniel P Petrylak; N Hammond; H M Gross; James A Eastham; E D Crawford
Southwest Oncology Group Study of paclitaxel and carboplatin for advanced transitional-cell carcinoma: the importance of survival as a clinical trial end point.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(13):2537-44.
2000: Caleb B Bozeman; BJ Williams; T Whatley; A Crow; James A Eastham
Clinical and biopsy specimen features in black and white men with clinically localized prostate cancer.
Southern medical journal 2000;93(4):400-2.
2000: C E Brekelbaum; F Abreo; M Fowler; William S Kubricht; James A Eastham
Undifferentiated sex cord/stromal testis tumor.
Urology 2000;55(3):436.
2000: Marco Marcelli; Michael Ittmann; S Mariani; Richard Sutherland; Rupesh Nigam; Lata J Murthy; Y Zhao; D DiConcini; Efisio Puxeddu; A Esen; James A Eastham; Nancy L Weigel; Dolores J Lamb
Androgen receptor mutations in prostate cancer.
Cancer research 2000;60(4):944-9.
2000: James A Eastham; Michael W Kattan
Disease recurrence in black and white men undergoing radical prostatectomy for clinical stage T1-T2 prostate cancer.
The Journal of urology 2000;163(1):143-5.
1999: William S Kubricht; BJ Williams; T Whatley; P Pinckard; James A Eastham
Serum testosterone levels in African-American and white men undergoing prostate biopsy.
Urology 1999;54(6):1035-8.
1999: Rosalyn M Adam; Joseph G Borer; J Williams; James A Eastham; K R Loughlin; M R Freeman
Amphiregulin is coordinately expressed with heparin-binding epidermal growth factor-like growth factor in the interstitial smooth muscle of the human prostate.
Endocrinology 1999;140(12):5866-75.
1999: M N Witte; Michael W Kattan; J Albani; D S Sharp; James A Eastham; Ronald A Morton
Race is not an independent predictor of positive surgical margins after radical prostatectomy.
Urology 1999;54(5):869-74.
1999: James A Eastham; R May; J L Robertson; O Sartor; Michael W Kattan
Development of a nomogram that predicts the probability of a positive prostate biopsy in men with an abnormal digital rectal examination and a prostate-specific antigen between 0 and 4 ng/mL.
Urology 1999;54(4):709-13.
1999: D Good; Paul Schwarzenberger; James A Eastham; R E Rhoads; Jay Hunt; M Collins; Mark A Batzer; Chris Theodossiou; Jay K Kolls; Sidney Grimes
Cloning and characterization of the prostate-specific membrane antigen promoter.
Journal of cellular biochemistry 1999;74(3):395-405.
1999: Brett S Carver; G B Zibari; V McBride; Dennis D Venable; James A Eastham
The incidence and implications of renal cell carcinoma in cadaveric renal transplants at the time of organ recovery.
Transplantation 1999;67(11):1438-40.
1999: William S Kubricht; RJ Henderson; W S Bundrick; Dennis D Venable; James A Eastham
Renal cell carcinoma in an intrathoracic kidney: radiographic findings and surgical considerations.
Southern medical journal 1999;92(6):628-9.
1999: O Sartor; James A Eastham
Progressive prostate cancer associated with use of megestrol acetate administered for control of hot flashes.
Southern medical journal 1999;92(4):415-6.
1999: William S Kubricht; Michael W Kattan; O Sartor; James A Eastham
Race is not independently associated with a positive prostate biopsy in men suspected of having prostate cancer.
Urology 1999;53(3):553-6.
1999: James A Eastham; K S Spires; F Abreo; J B Johnson; Dennis D Venable
Seminal vesicle abscess due to tuberculosis: role of tissue culture in making the diagnosis.
Southern medical journal 1999;92(3):328-9.
1999: O Sartor; Q Zheng; James A Eastham
Androgen receptor gene CAG repeat length varies in a race-specific fashion in men without prostate cancer.
Urology 1999;53(2):378-80.
1998: Michael W Kattan; James A Eastham; A M Stapleton; T M Wheeler; Peter T Scardino
A preoperative nomogram for disease recurrence following radical prostatectomy for prostate cancer.
Journal of the National Cancer Institute 1998;90(10):766-71.
1998: James A Eastham; R A May; T Whatley; A Crow; Dennis D Venable; O Sartor
Clinical characteristics and biopsy specimen features in African-American and white men without prostate cancer.
Journal of the National Cancer Institute 1998;90(10):756-60.
1998: K J Cline; John A Mata; Dennis D Venable; James A Eastham
Penetrating trauma to the male external genitalia.
The Journal of trauma 1998;44(3):492-4.
1998: James A Eastham; O Sartor
Nilutamide response after flutamide failure in post-orchiectomy progressive prostate cancer.
The Journal of urology 1998;159(3):990.
1997: P B Williams; James A Eastham; D J Culkin; John A Mata; Dennis D Venable; O Sartor
Influence of hepatic function on serum levels of prostate specific antigen.
The Journal of urology 1997;158(5):1867-9.
1997: James A Eastham; Michael W Kattan; S Groshen; Peter T Scardino; E Rogers; C E Carlton; Seth P Lerner
Fifteen-year survival and recurrence rates after radiotherapy for localized prostate cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(10):3214-22.
1997: M M Celebi; Dennis D Venable; C Nopajaroonsri; James A Eastham
Prostate cancer metastatic only to the penis.
Southern medical journal 1997;90(9):959-61.
1997: F T Siskron; Dennis D Venable; E Gonzalez; James A Eastham
Granulomatous mass in a nonrefluxing renal unit after bacillus Calmette-Guerin therapy for bladder cancer.
The Journal of urology 1997;158(3 Pt 1):882-3.
1997: RJ Henderson; R Germany; P W Peavy; James A Eastham; Dennis D Venable
Fat density in renal cell carcinoma: demonstration with computerized tomography.
The Journal of urology 1997;157(4):1347-8.
1997: RJ Henderson; James A Eastham; D J Culkin; Michael W Kattan; T Whatley; J Mata; Dennis D Venable; O Sartor
Prostate-specific antigen (PSA) and PSA density: racial differences in men without prostate cancer.
Journal of the National Cancer Institute 1997;89(2):134-8.
1996: B L Parra; Dennis D Venable; E Gonzalez; James A Eastham
Testicular microlithiasis as a predictor of intratubular germ cell neoplasia.
Urology 1996;48(5):797-9.
1996: James A Eastham; Michael W Kattan; E Rogers; J R Goad; Makoto Ohori; Timothy B Boone; Peter T Scardino
Risk factors for urinary incontinence after radical prostatectomy.
The Journal of urology 1996;156(5):1707-13.
1996: James A Eastham; T E Ahlering
Use of an anti-ras ribozyme to alter the malignant phenotype of a human bladder cancer cell line.
The Journal of urology 1996;156(3):1186-8.
1996: C Petrus; W S Bundrick; D J Culkin; James A Eastham
Spontaneous drainage of an appendiceal abscess into an orthotopic neobladder.
The Journal of urology 1996;155(6):2028.
1996: E Rogers; James A Eastham; Makoto Ohori; O Sariyuce; M Aihara; Thomas M Wheeler; Peter T Scardino
Impalpable prostate cancer: clinicopathological features.
British journal of urology 1996;77(3):429-32.
1996: James A Eastham; SH Chen; I Sehgal; Guang Yang; Terry L Timme; S J Hall; SL Woo; Timothy C Thompson
Prostate cancer gene therapy: herpes simplex virus thymidine kinase gene transduction followed by ganciclovir in mouse and human prostate cancer models.
Human gene therapy 1996;7(4):515-23.
1995: J R Goad; James A Eastham; K B Fitzgerald; Michael W Kattan; M P Collini; D H Yawn; Peter T Scardino
Radical retropubic prostatectomy: limited benefit of autologous blood donation.
The Journal of urology 1995;154(6):2103-9.
1995: James A Eastham; S J Hall; I Sehgal; Jin Wang; Terry L Timme; Guang Yang; L Connell-Crowley; Stephen J Elledge; W W Zhang; J Wade Harper
In vivo gene therapy with p53 or p21 adenovirus for prostate cancer.
Cancer research 1995;55(22):5151-5.
1995: James A Eastham; Luan D Truong; E Rogers; Michael W Kattan; K C Flanders; Peter T Scardino; Timothy C Thompson
Transforming growth factor-beta 1: comparative immunohistochemical localization in human primary and metastatic prostate cancer.
Laboratory investigation; a journal of technical methods and pathology 1995;73(5):628-35.
1995: James A Eastham; A M Stapleton; Angelo E Gousse; Terry L Timme; Guang Yang; Kevin Slawin; Thomas M Wheeler; Peter T Scardino; Timothy C Thompson
Association of p53 mutations with metastatic prostate cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 1995;1(10):1111-8.
1995: Timothy C Thompson; S H Park; Terry L Timme; Chengzhen Ren; James A Eastham; Lawrence A Donehower; Allan Bradley; Dov Kadmon; Guang Yang
Loss of p53 function leads to metastasis in ras+myc-initiated mouse prostate cancer.
Oncogene 1995;10(5):869-79.
1994: Makoto Ohori; J R Goad; Thomas M Wheeler; James A Eastham; Timothy C Thompson; Peter T Scardino
Can radical prostatectomy alter the progression of poorly differentiated prostate cancer?
The Journal of urology 1994;152(5 Pt 2):1843-9.
1994: John P Stein; D M Kaji; James A Eastham; JA Freeman; D Esrig; Brian E Hardy
Blunt renal trauma in the pediatric population: indications for radiographic evaluation.
Urology 1994;44(3):406-10.
1994: LE Crocitto; James A Eastham; L Zien; Eila C Skinner; J L Huffman
Management and evaluation of localized amyloidosis of the bladder: two case reports.
Urology 1994;44(2):282-4.
1994: James A Eastham; T Ahlering; E Skinner
Xanthogranulomatous pyelonephritis: clinical findings and surgical considerations.
Urology 1994;43(3):295-9.
1994: James A Eastham; T G Wilson; C Russell; T E Ahlering; Donald G Skinner
Surgical resection in patients with nonseminomatous germ cell tumor who fail to normalize serum tumor markers after chemotherapy.
Urology 1994;43(1):74-80.
1993: James A Eastham; T G Wilson; T E Ahlering
Urological evaluation and management of renal-proximity stab wounds.
The Journal of urology 1993;150(6):1771-3.
1993: James A Eastham; M L Esensten; T G Wilson
Isolated pulmonary metastases from prostatic adenocarcinoma.
The Western journal of medicine 1993;159(4):489-90.
1993: James A Eastham; J L Huffman
Technique of mitomycin C instillation in the treatment of upper urinary tract urothelial tumors.
The Journal of urology 1993;150(2 Pt 1):324-5.
1992: James A Eastham; T G Wilson; D W Larsen; T E Ahlering
Angiographic embolization of renal stab wounds.
The Journal of urology 1992;148(2 Pt 1):268-70.
1992: James A Eastham; T G Wilson; T E Ahlering
Radiographic evaluation of adult patients with blunt renal trauma.
The Journal of urology 1992;148(2 Pt 1):266-7.
1992: James A Eastham; T Wilson; S Boyd
Surgical management of urethral strictures based on etiology. Where do urethral stents fit in?
Urology 1992;40(2):110-2.
1992: James A Eastham; K McEvoy; R Sullivan; P Chandrasoma
A case of simultaneous bilateral nonseminomatous testicular tumors in persistent müllerian duct syndrome.
The Journal of urology 1992;148(2 Pt 1):407-8.
1992: James A Eastham; CJ Bennett
The occurrence of urologic injuries in patients with gunshot wounds to the spine.
Seminars in urology 1992;10(2):112-4.
1991: James A Eastham; T G Wilson; T E Ahlering
Radiographic assessment of blunt renal trauma.
The Journal of trauma 1991;31(11):1527-8.